HomeNews & MediaPress ReleasesPhilogen Receives Orphan Drug Designation for the Treatment of Soft Tissue SarcomaPress ReleasePublishedJanuary 8, 2019Philogen Receives Orphan Drug Designation for the Treatment of Soft Tissue SarcomaPRESS RELEASE FIBROMUN (opens in a new tab)